Calcium signalling in T cells
M Trebak, JP Kinet - Nature Reviews Immunology, 2019 - nature.com
Abstract Calcium (Ca2+) signalling is of paramount importance to immunity. Regulated
increases in cytosolic and organellar Ca2+ concentrations in lymphocytes control complex …
increases in cytosolic and organellar Ca2+ concentrations in lymphocytes control complex …
The ectonucleotidases CD 39 and CD 73: novel checkpoint inhibitor targets
Cancers are able to grow by subverting immune suppressive pathways, to prevent the
malignant cells as being recognized as dangerous or foreign. This mechanism prevents the …
malignant cells as being recognized as dangerous or foreign. This mechanism prevents the …
The P2X7 receptor in inflammatory diseases: angel or demon?
LEB Savio, P de Andrade Mello… - Frontiers in …, 2018 - frontiersin.org
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the
extracellular milieu, being massively released by stressed or dying cells. Once outside the …
extracellular milieu, being massively released by stressed or dying cells. Once outside the …
Purinergic signalling: therapeutic developments
G Burnstock - Frontiers in pharmacology, 2017 - frontiersin.org
Purinergic signalling, ie, the role of nucleotides as extracellular signalling molecules, was
proposed in 1972. However, this concept was not well accepted until the early 1990's when …
proposed in 1972. However, this concept was not well accepted until the early 1990's when …
Extracellular purines, purinergic receptors and tumor growth
F Di Virgilio, E Adinolfi - Oncogene, 2017 - nature.com
Virtually, all tumor cells as well as all immune cells express plasma membrane receptors for
extracellular nucleosides (adenosine) and nucleotides (ATP, ADP, UTP, UDP and sugar …
extracellular nucleosides (adenosine) and nucleotides (ATP, ADP, UTP, UDP and sugar …
The P2X7 receptor: central hub of brain diseases
R Andrejew, Á Oliveira-Giacomelli… - Frontiers in Molecular …, 2020 - frontiersin.org
The P2X7 receptor is a cation channel activated by high concentrations of adenosine
triphosphate (ATP). Upon long-term activation, it complexes with membrane proteins forming …
triphosphate (ATP). Upon long-term activation, it complexes with membrane proteins forming …
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
G Burnstock, GE Knight - Purinergic signalling, 2018 - Springer
Seven P2X ion channel nucleotide receptor subtypes have been cloned and characterised.
P2X7 receptors (P2X7R) are unusual in that there are extra amino acids in the intracellular …
P2X7 receptors (P2X7R) are unusual in that there are extra amino acids in the intracellular …
The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
E De Marchi, E Orioli, A Pegoraro, S Sangaletti… - Oncogene, 2019 - nature.com
In the tumor microenvironment (TME) ATP and its receptor P2X7 exert a pivotal influence on
cancer growth and tumor–host interactions. Here we analyzed the different effect of P2X7 …
cancer growth and tumor–host interactions. Here we analyzed the different effect of P2X7 …
Damage-associated molecular patterns in cancer: a double-edged sword
Damage-associated molecular patterns (DAMPs) are released in response to cell death and
stress, and are potent triggers of sterile inflammation. Recent evidence suggests that DAMPs …
stress, and are potent triggers of sterile inflammation. Recent evidence suggests that DAMPs …
The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases
Immune-mediated inflammatory diseases (IMIDs) encompass a wide range of seemingly
unrelated conditions, such as multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory …
unrelated conditions, such as multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory …